Skip to nav Skip to content

50 article(s) found

A vial of blood identified as from a Multiple Myeloma patient

Identifying Patients at Risk of Multiple Myeloma Relapse Can Improve Treatment Plans

Moffitt researchers lead national effort to refine risk-stratification tools to improve patient outcomes

Ciara Freeman, MD, PhD, specializes in treating people with multiple myeloma, a blood cancer that starts in plasma cells in the bone marrow.

Physician-Scientist Explores How AI Can Improve Treatment Decisions

Ciara Freeman, MD, PhD, and her colleagues are combining data in an AI platform to uncover patterns that clinicians can use to guide real-time decisions 

From Family Loss to Scientific Purpose: How One PhD Candidate Found His Path at Moffitt

Moffitt’s Cancer Biology PhD Program continues to grow, attracting students from around the world

photo of Jasmine Cherry with her brother

Navigating Survivorship After Bone and Marrow Transplant

Moffitt experts and leukemia survivor share candid insights and support resources

Jackie Rowe and Maria Chambers play a game of pickleball at the Greater Palm Harbor YMCA. Both women participated in Project Rally, which invited cancer survivors and family or friends to pick up the sport as a source of physical activity.

Pickleball Keeps Cancer Survivors on Their Toes, Moffitt Study Shows

Partnership program with YMCA motivated survivors to increase activity, connect with others

Access to Treatment is Hurdle to be Conquered for Multiple Myeloma Patients

CAR T treatments have revolutionized care, but some communities struggle to receive it

The Power of Fiber: How Diet Can Help Fight Cancer and Improve Recovery

From help with stem cell transplants to delays in progression, fiber has the potential to unlock new benefits in the fight against cancer

Moffitt Study Finds New Genetic Clues to Resistance in Multiple Myeloma Treatments

Study reveals genetic markers that predict treatment resistance, offering potential for more personalized therapy plans

New CAR T-Cell Therapy Shows Promising Results for Advanced Multiple Myeloma

Early trial results show high success rates and manageable side effects